CAS: 181630-15-9 - Picoplatin
Formula:C6H10Cl2N2Pt
InChI:InChI=1S/C6H7N.2ClH.H3N.Pt/c1-6-4-2-3-5-7-6;;;;/h2-5H,1H3;2*1H;1H3;/q;;;;+2/p-2
InChI key:InChIKey=IIMIOEBMYPRQGU-UHFFFAOYSA-L
SMILES:[Cl-][Pt+2]([Cl-])([N]=1C=CC=CC1C)[NH3]
- Synonyms:
- (SP-4-3)-Amminedichloro(2-methylpyridine)platinum
- Amd 473
- Amminedichloro(2-methylpyridine)platinium
- Nx 473
- Platinum(2+) Chloride - 2-Methylpyridine Ammoniate (1:2:1:1)
- Platinum, amminedichloro(2-methylpyridine)-, (SP-4-3)-
- Zd 0473
- Zd0473
- Picoplatin
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Platinum, amminedichloro(2-methylpyridine)-, (SP-4-3)- REF: IN-DA002306CAS: 181630-15-9 | 96% | To inquire | Tue 10 Dec 24 | |
Picoplatin REF: 7W-GP0248CAS: 181630-15-9 | - - - | To inquire | Tue 10 Dec 24 | |
Picoplatin REF: 3D-FP65130CAS: 181630-15-9 | Min. 97 Area-% | To inquire | Thu 19 Dec 24 | |
Picoplatin REF: TM-T21323CAS: 181630-15-9 | 98% | To inquire | Tue 28 Jan 25 |
Platinum, amminedichloro(2-methylpyridine)-, (SP-4-3)-
CAS:181630-15-9
Formula:
C6H10Cl2N2Pt
Purity:
96%
Color and Shape:
Solid
Molecular weight:
376.1410
Ref: IN-DA002306
10mg | 61.00 € | ||
50mg | 177.00 € | ||
250mg | 640.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 7W-GP0248
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Picoplatin
CAS:181630-15-9
Platinum-based anti-cancer agent; induces apoptosis
Formula:
C6H7N•PtCl2•NH3
Purity:
Min. 97 Area-%
Color and Shape:
Powder
Molecular weight:
376.15 g/mol
Ref: 3D-FP65130
25mg | 136.00 € | ||
50mg | 152.00 € | ||
100mg | 213.00 € | ||
250mg | 400.00 € | ||
500mg | 568.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Picoplatin
CAS:181630-15-9
Picoplatin, an anti-cancer agent overcoming platinum resistance, alkylates DNA to block replication, transcription, and induce …
Formula:
C6H10Cl2N2Pt
Purity:
98%
Color and Shape:
Solid
Molecular weight:
376.14
Ref: TM-T21323
25mg | 1,415.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025